News
Truist Financial Corp. Dep. Pfd. (Rep. 1/1000th Perp. Pfd. Series R) 1.36% Truist Financial Corp. Dep. Pfd. (Rep. 1/1000th Perp. Pfd. Series O) 1.06% Truist Financial ...
U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L) 1.28% U.S. Bancorp Dep. Pfd. (Rep. 1/1000 Interest in a share of Non-Cum Perp Pfd Series B) 1.06% U.S. Bancorp Dep. Pfd. (Rep. 1 ...
Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and large-scale manufacturing for allogeneic cell therapies. Advancing GPCR drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback